Lilly accelerating baricitinib’s availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements
INDIANAPOLIS-- Eli Lilly and Company announces new initiatives to help COVID-19 patients in India as part of its commitment to bring the...